News & Events

October 13, 2011

Medafor Recognized as One of Minneapolis’ Fastest-Growing Private Companies by Minneapolis/St. Paul Business Journal

MINNEAPOLIS, MN October 13, 2011 - Medafor Inc. has been recognized on the Minneapolis / St Paul Business Journal’s annual “Fast 50” list, which honors the 50 fastest-growing private companies in the Twin Cities. Medafor is ranked 17 of 50 based on its three-year aggregate growth of 95.84%.

Gary Shope, CEO of Medafor, said: “We are delighted to have been recognized as one of the fastest growing companies in the Twin Cities area. Our commitment to investing in our people, our research, and our unique hemostatic technology, combined with our entrepreneurial and dedicated sales force, has enabled us to achieve record growth over the past three years. We look forward to building on this momentum as we continue to develop ground-breaking products and technologies that address market needs.”

The Minneapolis / St Paul Business Journal’s “Fast 50” award list represents an annual ranking of the fastest growing private companies in Minnesota. The list ranks companies based on three-year revenue growth. The ranking was published in the October 7, 2011 issue of the Minneapolis / St Paul Business Journal.

About Medafor Inc.

Medafor is a privately held Minnesota corporation based in Minneapolis. Medafor was founded to develop applications and markets for its patented, plant-based, flowable hemostatic powder technology. MPH^® is a microporous, polysaccharide hemostatic agent that is engineered to rapidly dehydrate blood and accelerate clotting. Medafor received FDA approval for surgical use in 2006 and has held a CE Mark approval since 2003.